HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 1, 2006--Guava Technologies, Inc., a leading developer of cost-effective and accessible cell-analysis systems for life science research, drug discovery, development and clinical diagnostics, today announced the introduction of RapidQuant(TM) IgG kits, a new line of quantitative bead-based kits designed to quantify either mouse or human IgG antibody (Immunoglobulin G) during hybridoma screening.
